XML 39 R28.htm IDEA: XBRL DOCUMENT
v3.19.2

Related Parties Transactions (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2019
Related Party Transactions [Abstract] |
Schedule of related party transactions |
Name of entity or Individual |  | Relationship with the Company and its subsidiaries
BioFirst Corporation (the "BioFirst") |  | Collaborative partners; Shareholder of the Company; Entity controlled by controlling beneficiary shareholder of YuanGene
BioFirst (Australia) Pty Ltd. (the "BioFirst (Australia)") |  | 100% owned by BioFirst; Entity controlled by controlling beneficiary shareholder of YuanGene
LBG USA, Inc. (the "LBG USA") |  | 100% owned by BioFirst; Entity controlled by controlling beneficiary shareholder of YuanGene
Lion Arts Promotion Inc. (the "LION") |  | Shareholder of the Company; Controlling shareholder of BioLite Inc.
LionGene Corporation (the "LionGene") |  | Shareholder of the Company; Entity controlled by controlling beneficiary shareholder of YuanGene
BioHopeKing Corporation (the "BHK") |  | Collaborative partners, BioLite Inc. owns 7.13% of BHK's common stock and serves as the Supervisor of BHK, Chi-Chou Liao, the Chairman of BHK, is also the shareholder of the Company.
Rgene Corporation (the "Rgene") |  | Collaborative partners; Shareholder of the Company; Entity controlled by controlling beneficiary shareholder of YuanGene
YuanGene Corporation (the "YuanGene") |  | Controlling beneficiary shareholder of the Company
AsiaGene Corporation (the "AsiaGene") |  | Shareholder of the Company; Entity controlled by controlling beneficiary shareholder of YuanGene
Keypoint Technology Ltd. (the "Keypoint') |  | The Chairman of Keypoint is Shu-Ling Jiang.
Yoshinobu Odaira (the "Odaira") |  | Director of the Company
GenePharm Inc. (the "GenePharm") |  | Mr. George Lee, the Director and Chairman of Biokey, is the Chairman of GenePharm.
Mr. Tsung-Shann Jiang, Ms. Shu-Ling Jiang, Mr. Chang-Jen Jiang, Ms. Mei-Ling Jiang, and Mr. Eugene Jiang (collectively the "Jiangs") |  | Mr. Tsung-Shann Jiang, the controlling beneficiary shareholder of the Company and Rgene, the Chairman and CEO of the BioLite Holding Inc. and BioLite Inc. and the President and a member of board of directors of BioFirst Ms. Shu-Ling Jiang, Mr. Tsung-Shann Jiang's wife, is the Chairman of Keypoint, LION, and BioFirst; and a member of board of directors of BioLite Inc. Mr. Eugene Jiang is Mr. and Ms. Jiang's son. Mr. Eugene Jiang is the chairman, and majority shareholder of the Company and a member of board of directors of BioLite Inc. Mr. Chang-Jen Jiang is Mr. Tsung-Shann Jiang's sibling and the director of the Company. Ms. Mei-Ling Jiang is Ms. Shu-Ling Jiang's sibling.
Schedule of accounts receivable related parties |
|  | June 30, |  |  | December 31, |
|  | 2019 |  |  | 2018 |
GenePharm Inc. |  | $ | 142,225 |  |  | $ | - |
Total |  | $ | 142,225 |  |  | $ | - |
Schedule of due from related parties |
|  | June 30, |  |  | December 31, |
|  | 2019 |  |  | 2018 |
Rgene Corporation |  | $ | 25,025 |  |  | $ | 19,477 |
AsiaGene Corporation |  |  | 3,256 |  |  |  | - |
BioFirst (Australia) Pty Ltd. |  |  | 40,000 |  |  |  | 40,000 |
BioHopeKing Corporation |  |  | 111,780 |  |  |  | - |
LBG USA Inc. |  |  | 675 |  |  |  | - |
Total |  | $ | 180,736 |  |  | $ | 59,477 |
Schedule of amount due to related party |
|  | June 30, |  |  | December 31, |
|  | 2019 |  |  | 2018 |
Lion Arts Promotion Inc |  | $ | 97,864 |  |  | $ | 65,495 |
LionGene Corporation |  |  | 428,099 |  |  |  | 458,348 |
BioFirst Corporation |  |  | 3,002,911 |  |  |  | 6,428,643 |
AsiaGene Corporation |  |  | 160,000 |  |  |  | 160,000 |
YuanGene Corporation |  |  | 92,690 |  |  |  | 92,690 |
The Jiangs |  |  | 1,198,729 |  |  |  | 539,920 |
Total |  | $ | 4,980,293 |  |  | $ | 7,745,096 |

X
- Definition Tabular disclosure of due from related parties. + References No definition available. + Details
Name: | abvcd_ScheduleOfDueFromRelatedPartiesTableTextBlock
Namespace Prefix: | abvcd_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of related party transactions. Amount due to related party. + References No definition available. + Details
Name: | abvcd_ScheduleOfRelatedPartyTransactionsAmountDueToRelatedParty
Namespace Prefix: | abvcd_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RelatedPartyTransactionsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.3,4) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates. + References No definition available. + Details
Name: | us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration